Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |